Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Publication section now includes a note that items are automatically filled from PubMed and may not be about the study. The revision version has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:52:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The government funding/operating-status notice at the bottom of the page was removed, removing guidance about potential site-wide delays and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T08:38:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The two screenshots show only minor layout and formatting adjustments to the study details page, with no changes to core study content (title, identifiers, eligibility criteria, design, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:13:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding the core content to include genetics-related information on this disease. No deletions. If this is a medical information page, expect broader coverage on genetics and multiple myeloma.
    Difference
    0.2%
    Check dated 2025-10-21T01:31:05.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T16:04:42.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Adds broader topic coverage (Multiple myeloma) and updates version to v3.1.0; removes the previous MedlinePlus Genetics topic link and the term 'Plasma cell myeloma' plus older revision v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-29T09:59:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.